A new research paper was published on the cover of Aging entitled "Glutaminase inhibitors rejuvenate human skin via clearance of senescent cells: a study using a mouse/human chimeric model."
Dec 1, 2022
0
28
A research team at LKS Faculty of Medicine, The University of Hong Kong (HKUMed) has discovered that high glucose impairs the anti-tumor activity of immune effector gamma delta T cells (γδ-T cells), which contributes to ...
Nov 29, 2022
0
8
New research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London has demonstrated that brain wiring requires the control of local protein synthesis at the level of specific synapse ...
Nov 25, 2022
0
73
As people age, maintaining a positive and predictable social environment becomes more and more important. For instance, keeping close ties with friends and family has been identified as one of the key ingredients to healthy ...
Nov 24, 2022
0
610
A new research paper titled "Krill oil protects dopaminergic neurons from age-related degeneration through temporal transcriptome rewiring and suppression of several hallmarks of aging" has been published in Aging.
Nov 23, 2022
0
35
A new research paper has been published in Aging entitled "The deubiquitylase USP7 is a novel cyclin F-interacting protein and regulates cyclin F protein stability."
Nov 22, 2022
0
0
A new research paper titled "IGF1 gene therapy in middle-aged female rats delays reproductive senescence through its effects on hypothalamic GnRH and kisspeptin neurons" has been published in Aging.
Nov 16, 2022
0
8
Angelman syndrome is a genetic disease that causes a developmental delay, alterations in speech and balance, intellectual disability and sometimes, seizures. To date, researchers had identified mutations in the HERC2 gene, ...
Nov 15, 2022
0
18
As differently as cancers or autoimmune diseases (such as multiple sclerosis, rheumatoid arthritis or psoriasis) affect people, they all have one characteristic in common: they are accompanied by increased cell proliferation. ...
Nov 14, 2022
0
40
An interdisciplinary research team led by UCLA found that a drug already approved by the Food and Drug Administration for eye disease, verteporfin, stopped the replication of SARS-CoV-2, the virus that causes COVID-19. Their ...
Nov 8, 2022
0
51
